Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
ENB-104 by Ennovabio for Peripheral T-Cell Lymphomas (PTCL): Likelihood of Approval
ENB-104 is under clinical development by Ennovabio and currently in Phase I for Peripheral T-Cell Lymphomas (PTCL). According to GlobalData,...
Data Insights
ENB-104 by Ennovabio for Inflammatory Bowel Disease: Likelihood of Approval
ENB-104 is under clinical development by Ennovabio and currently in Phase I for Inflammatory Bowel Disease. According to GlobalData, Phase...